AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results - Nasdaq

AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results  Nasdaq

Announces name change to Beyond Air™. Completed uplisting to the NASDAQ and $7.96 million PIPE financing. Anticipate PMA submission in the third.



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today